You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) GLYCERYL MONO AND DIPALMITOSTEARATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing GLYCERYL MONO AND DIPALMITOSTEARATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing GLYCERYL MONO AND DIPALMITOSTEARATE excipient

GLYCERYL MONO AND DIPALMITOSTEARATE Market Analysis and Financial Projection Experimental

Glyceryl Mono and Dipalmitostearate: Market Dynamics and Financial Trajectory

Introduction

Glyceryl mono and dipalmitostearate, derivatives of glycerol, are versatile excipients used across various industries, including pharmaceuticals, food, and cosmetics. These compounds play crucial roles as emulsifiers, thickening agents, and stabilizers. Here, we delve into the market dynamics and financial trajectory of these pharmaceutical excipients.

Market Size and Growth

The market for glyceryl monostearate, a closely related compound, was valued at USD 989.23 million in 2022 and is projected to reach USD 1,314.76 million by 2030, growing at a CAGR of 3.62% during the forecast period[1].

Market Segmentation

By Product Type

Glyceryl mono and dipalmitostearate are categorized based on their application:

  • Emulsifier: Commonly used in pharmaceuticals to stabilize mixtures of oil and water.
  • Thickening Agent: Used in various formulations to adjust viscosity.
  • Anti-Caking Agent: Prevents the formation of lumps in powdered products.
  • Stabilizer: Ensures the stability of formulations over time[1].

By Application

The primary applications include:

  • Pharmaceuticals: As excipients in drug formulations to enhance bioavailability, stability, and patient acceptability.
  • Food and Beverages: As food additives to improve texture and stability.
  • Personal Care and Cosmetics: In skincare and haircare products for their emollient properties[1].

Drivers of Market Growth

Increased Utilization Across End-Users

Glyceryl mono and dipalmitostearate are widely used due to their multifunctional properties. In pharmaceuticals, they are essential for improving the bioavailability and stability of drugs. The increasing demand for processed foods and the growing need for effective cosmetic products also drive market growth[1].

Surging Awareness and Investments

Pharmaceutical companies are investing heavily in research and development, which extends profitable opportunities for glyceryl mono and dipalmitostearate. The rising awareness about the benefits of these excipients further expands their market potential[1].

Opportunities

Expanding Pharmaceutical Excipients Market

The global pharmaceutical excipients market, which includes glyceryl mono and dipalmitostearate, is expected to grow significantly. The market size is projected to increase from USD 8.37 billion in 2023 to approximately USD 14.72 billion by 2033, growing at a CAGR of 5.81%[3].

Growing Demand in Developing Economies

The continuous increase in demand for processed food and personal care products in developing economies presents a lucrative opportunity for the market. Countries in the Asia-Pacific region, in particular, are expected to show significant growth due to the presence of major manufacturers and a rising dairy industry[1].

Restraints and Challenges

Health Consciousness and Veganism Trends

Rising health consciousness among consumers and the increasing trend towards veganism and meat-free diets pose challenges to the market. These trends can reduce the demand for glyceryl mono and dipalmitostearate in food and beverage applications[1].

Geographical Analysis

North America

North America dominates the glyceryl monostearate market due to the high demand for processed food and the growing beauty and personal care sector. The region's pharmaceutical excipients market, which includes glyceryl mono and dipalmitostearate, was valued at USD 3.15 billion in 2023 and is projected to grow at a CAGR of 6.04% from 2024 to 2033[1][3].

Asia-Pacific

The Asia-Pacific region is expected to show significant growth due to the sharp rise in the dairy industry and the presence of major manufacturers. This region is anticipated to become a key market for glyceryl mono and dipalmitostearate in the coming years[1].

Safety and Regulatory Considerations

Safety Assessment

Glyceryl diesters, including glyceryl mono and dipalmitostearate, have undergone extensive safety assessments. Studies have shown that these compounds are generally safe for use in cosmetics and pharmaceuticals. For instance, the Cosmetic Ingredient Review (CIR) has evaluated the safety of glyceryl diesters, including glyceryl distearate and glyceryl dioleate, and found no significant adverse effects[5].

Regulatory Framework

Regulations on the use of glyceryl mono and dipalmitostearate vary by region. In the pharmaceutical sector, these excipients must comply with FDA guidelines and other international standards to ensure safety and efficacy[5].

Financial Trajectory

Market Value

The glyceryl monostearate market, which is closely related to glyceryl mono and dipalmitostearate, is expected to grow from USD 989.23 million in 2022 to USD 1,314.76 million by 2030. This growth is driven by increasing demand across various end-use industries[1].

Revenue Streams

The revenue streams for glyceryl mono and dipalmitostearate are diverse:

  • Pharmaceutical Sector: Expected to grow due to the increasing demand for new drug formulations and the expanding generics market.
  • Food and Beverages: Driven by the continuous increase in demand for processed foods.
  • Personal Care and Cosmetics: Growing due to the increasing demand for luxury cosmetic brands and the shift towards high-quality skincare products[1][3].

Key Takeaways

  • The market for glyceryl mono and dipalmitostearate is driven by their multifunctional properties and increasing demand across pharmaceuticals, food, and cosmetics.
  • The global pharmaceutical excipients market, which includes these compounds, is expected to grow significantly by 2033.
  • North America and the Asia-Pacific region are key markets due to high demand and the presence of major manufacturers.
  • Safety assessments and regulatory compliance are crucial for the use of these excipients.

FAQs

What are the primary applications of glyceryl mono and dipalmitostearate?

Glyceryl mono and dipalmitostearate are primarily used as emulsifiers, thickening agents, and stabilizers in pharmaceuticals, food and beverages, and personal care products.

How is the market for glyceryl monostearate expected to grow?

The glyceryl monostearate market is expected to grow from USD 989.23 million in 2022 to USD 1,314.76 million by 2030, at a CAGR of 3.62%.

What are the key drivers of the market growth for glyceryl mono and dipalmitostearate?

The key drivers include increased utilization across end-users, surging awareness and investments in research and development, and growing demand in developing economies.

Which regions dominate the market for glyceryl mono and dipalmitostearate?

North America currently dominates the market, while the Asia-Pacific region is expected to show significant growth in the coming years.

Are glyceryl mono and dipalmitostearate safe for use?

Extensive safety assessments have shown that glyceryl diesters, including glyceryl mono and dipalmitostearate, are generally safe for use in cosmetics and pharmaceuticals.

Sources

  1. Data Bridge Market Research: Global Glycerol Monostearate Market Size & Industry Trends By 2030.
  2. SAGE Journals: Amended Final Report on the Safety Assessment of Glyceryl.
  3. GlobeNewswire: Pharmaceutical Excipients Market Size Expected to Reach USD 14.72 Bn by 2033.
  4. ACS Publications: Solid Lipid Microparticles for Oral Delivery of Catalase.
  5. CIR Safety Assessment: Safety Assessment of Glyceryl Diesters as Used in Cosmetics.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.